Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

Passion is an important word in Georgina Long’s lexicon. It’s the drive that has stamped her as an internationally renowned ...

Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically explore how large language models (LLMs) can ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

While oncology has relentlessly pursued progress through pharmacological and procedural advances, exercise has occupied a ...

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically ...

In a newly published article in Nature Genetics, researchers from the University of Chicago have identified tumor ...